140 related articles for article (PubMed ID: 6376482)
1. Defining the boundaries of atypical depression.
Quitkin FM; Harrison W; Liebowitz M; McGrath P; Rabkin JG; Stewart J; Markowitz J
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):19-21. PubMed ID: 6376482
[TBL] [Abstract][Full Text] [Related]
2. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
McGrath PJ; Stewart JW; Harrison WM; Ocepek-Welikson K; Rabkin JG; Nunes EN; Wager SG; Tricamo E; Quitkin FM; Klein DF
J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
[TBL] [Abstract][Full Text] [Related]
5. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacologic validation of atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
[TBL] [Abstract][Full Text] [Related]
7. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
[TBL] [Abstract][Full Text] [Related]
8. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
Thase ME; Frank E; Mallinger AG; Hamer T; Kupfer DJ
J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
[TBL] [Abstract][Full Text] [Related]
9. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
Parsons B; Quitkin FM; McGrath PJ; Stewart JW; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin JG; Wager SG; Nunes E
Psychopharmacol Bull; 1989; 25(4):524-34. PubMed ID: 2698483
[TBL] [Abstract][Full Text] [Related]
10. Chronic depression: response to placebo, imipramine, and phenelzine.
Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
[TBL] [Abstract][Full Text] [Related]
11. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant specificity in atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
[TBL] [Abstract][Full Text] [Related]
13. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
Stewart JW; McGrath PJ; Quitkin FM
Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
[TBL] [Abstract][Full Text] [Related]
14. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
[TBL] [Abstract][Full Text] [Related]
15. [Impact of personality factors in depression].
Quitkin FM
Encephale; 1993 Aug; 19 Spec No 3():491-2. PubMed ID: 8299548
[TBL] [Abstract][Full Text] [Related]
16. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
17. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences.
Matza LS; Revicki DA; Davidson JR; Stewart JW
Arch Gen Psychiatry; 2003 Aug; 60(8):817-26. PubMed ID: 12912765
[TBL] [Abstract][Full Text] [Related]
18. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
[TBL] [Abstract][Full Text] [Related]
19. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
20. Phenelzine v imipramine in atypical depression. A preliminary report.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
